BELL Belluscura Plc

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, AUSTRALIA, NEW ZEALAND, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND SHALL NOT CONSTITUTE AN OFFER TO SELL OR ISSUE OR THE SOLICITATION OF AN OFFER TO BUY, SUBSCRIBE FOR OR OTHERWISE ACQUIRE ANY NEW SHARES OF BELLUSCURA PLC.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("UK MAR"), AND IS DISCLOSED IN ACCORDANCE WITH THE COMPANY'S OBLIGATIONS UNDER ARTICLE 17 OF MAR. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, SUCH INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

12 February 2025

Belluscura plc

("Belluscura" or the "Company")

Posting of Circular and Notice of General Meeting

Belluscura plc (AIM: BELL), a UK medical device company focused on developing oxygen enrichment technology spanning broad industries and therapies, announces that further to the announcements made on 6, 7 and 11  February 2025, a circular (the "Circular"), including the Notice of General Meeting, was posted to shareholders on 11 February 2025 with details of the Fundraising and putting forward Resolutions to enable completion of the Fundraising.

The General Meeting will be held at the offices of Dowgate Capital Limited, 15 Fetter Lane, London EC4A 1BW at 11.00 a.m. on 28 February 2025

 A copy of the Circular will shortly be available on the Company's website at www.belluscura.com.

In order for eligible Shareholders to be able to qualify for VCT/EIS relief, the WRAP Retail Offer Shares are expected to be issued and admitted to trading on AIM on or around 4 March 2025, along with  56,534,389 VCT/EIS Placing Shares (subject to the passing of the Resolutions) and the remaining  109,616,986 Conditional Placing Shares are expected to be issued and admitted to trading on AIM on or around 5 March 2025 (subject to the passing of the Resolutions).  Accordingly, the WRAP Retail Offer is no longer conditional on completion of the issue of the 109,616,986 Conditional Placing Shares, being the final tranche of New Ordinary Shares to be issued pursuant to the Fundraising.

 EXPECTED TIMETABLE OF PRINCIPAL EVENTS

Notes:

1.References to times and dates in this Document are to London times and dates unless otherwise stated.

2.If any of the above times or dates should change, the revised times and/or dates will be notified to Shareholders by an announcement on an RIS (and posted on the Company's website).

3.All events in the above timetable following the General Meeting, in particular the issue of the New Ordinary Shares by the Company, are conditional upon approval by the Shareholders of the Resolutions.

4.If any of the details contained in the timetable above should change, the revised times and dates will be notified to Shareholders by means of an announcement through a Regulatory Information Service.

Capitalised terms used in this announcement shall, unless otherwise defined, have the same meanings as set out in the Company's announcement of 7 February 2025 and the Circular.

Enquiries:

For further information please contact:

For further information, please visit https://ir.belluscura.com/